Contify, a leading AI-native Market and Competitive Intelligence (M&CI) platform, today launched Athena, its proprietary Agentic AI insights engine. Athena eliminates manual M&CI work and delivers trusted, decision-ready market and competitor insights, with enterprise-grade accuracy. It enables organizations to make faster, more confident decisions and compete with greater agility. https://mma.prnewswire.com/media/2724338/Contify_Logo.jpg Unlike generic AI assistants like […]

NEW YORK, NY / ACCESS Newswire / July 3, 2025 / If you suffered a loss on your Red Cat Holdings, Inc. (NASDAQ:RCAT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/red-cat-holdings-inc-lawsuit-submission-form?prid=155460&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Luminar Technologies, Inc. ("Luminar" or the "Company") (NASDAQ:LAZR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Luminar and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of NeuroPace, Inc. ("NeuroPace" or the "Company") (NASDAQ:NPCE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeuroPace and certain of its officers and/or directors

NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Quipt and certain of its officers

NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ:SRPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

NEW YORK, NY / ACCESS Newswire / July 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Neogen Corporation ("Neogen" or "the Company") (NASDAQ:NEOG). Investors who purchased Neogen securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/NEOG. Investigation Details

NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sable Offshore Corp. ("Sable" or "the Company") (NYSE:SOC). Investors who purchased Sable securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SOC.

NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ:NXT). Investors who purchased Nextracker securities prior to February 1, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / July 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged